Irish Regulator Invites Feedback On Strategic Plan For 2021-2025
Period Will Likely See Uncertainty And Changes In Regulatory Environment
Executive Summary
Ireland’s drug and medical device regulator is seeking stakeholder views on what its priorities should be over the next five years, given the uncertainties of Brexit and impending regulatory changes.